Department of Gastroenterology and Hepatology, Gunma University Graduate School of Medicine, Gunma, Japan.
Department of Gastroenterology, Juntendo University School of Medicine, Tokyo, Japan.
Dig Endosc. 2024 Sep;36(9):1003-1011. doi: 10.1111/den.14752. Epub 2024 Feb 1.
We previously demonstrated that a favorable long-term prognosis indicated that endoscopic submucosal dissection (ESD) could be the standard treatment for large colorectal epithelial neoplasms, but the usefulness of ESD for local residual or recurrent tumors with submucosal fibrosis has not been fully demonstrated. The aim of the present study was to assess the usefulness of ESD for local residual or recurrent colorectal tumors.
We conducted a nationwide multicenter prospective study to evaluate the outcomes of ESD for colorectal tumors. In this post hoc analysis, a total of 54 local residual or recurrent colorectal tumors in 54 patients were included, and we analyzed the short-term and long-term outcomes of ESD for these lesions.
The median size of the lesions was 16.0 (interquartile range [IQR] 11-25) mm. ESD was completed in 53 cases (98.1%) with a median procedure time of 65.0 min, but it was discontinued in one case because of submucosal cancer invasion. En bloc resection was achieved in 52 cases (96.3%), whereas R0 resection was achieved in 45 cases (83.3%). Intraoperative perforation was observed in four cases (7.4%) and delayed perforation in one (1.9%), but all cases could be managed conservatively. Delayed bleeding was not observed. There were no significant differences in short-term outcomes between the rectal and colonic lesions. There was no recurrence of the tumor during the median follow-up period of 60 (IQR 50-64) months.
An analysis of our multicenter prospective study suggests that ESD is an effective salvage management for local residual or recurrent colorectal lesions.
我们之前的研究表明,良好的长期预后表明内镜黏膜下剥离术(ESD)可以作为大肠上皮肿瘤的标准治疗方法,但 ESD 对于合并黏膜下纤维化的局部残留或复发性肿瘤的有效性尚未得到充分证实。本研究旨在评估 ESD 对大肠局部残留或复发性肿瘤的作用。
我们进行了一项全国多中心前瞻性研究,以评估 ESD 治疗大肠肿瘤的疗效。在本回顾性分析中,共纳入 54 例 54 个局部残留或复发性大肠肿瘤患者,分析了 ESD 治疗这些病变的近期和远期疗效。
病变的中位大小为 16.0(四分位间距[IQR]11-25)mm。ESD 可完成 53 例(98.1%),中位手术时间为 65.0min,但因黏膜下癌症侵犯而中断 1 例。52 例(96.3%)整块切除,45 例(83.3%)达到 R0 切除。术中穿孔 4 例(7.4%),延迟穿孔 1 例(1.9%),但均能保守治疗。无延迟性出血。直肠和结肠病变的短期结果无显著差异。中位随访 60(IQR 50-64)个月期间,肿瘤无复发。
多中心前瞻性研究的分析表明,ESD 是治疗大肠局部残留或复发性肿瘤的有效挽救性治疗方法。